Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder
✍ Scribed by Stefan Hinz; Carsten Kempkensteffen; Frank Christoph; Michèle Hoffmann; Hans Krause; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 393 KB
- Volume
- 134
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The FHIT gene, located at human chromosome 3p14.2, frequently is deleted in a number of human tumors, including breast carcinoma. Its protein product (Fhit) is presumed to have tumor suppressor function. Loss of expression of a tumor suppressor gene is an important step in tumor prog
## BACKGROUND. The progression of solid tumors is at least partly dependent on angiogenesis, the induction of which is mediated by several angiogenic factors, including angiogenin (ANG). The authors evaluated the expression of ANG in the tumor tissue and serum of patients with urothelial carcinoma
## Abstract __AIB1__, a candidate oncogene in human breast cancer, is frequently amplified and overexpressed in several types of human cancers, but the status of __AIB1__ amplification and expression in urothelial carcinoma of the bladder (UC) and its clinical/prognostic significance is unclear. In